The focus of this renewal is on understanding the molecular consequences of neurotrophic factors and how these molecular interactions change in the aged brain. During the past funding period, we have demonstrated that BDNI and GNDF can regulate the transcription of the GIuR2 receptor via the neuron-restrictive silencer element (NRSE). Concomitantly, our colleagues in project 15 have shown an increase in GIuR2 synthesis in late-phase LTP. There is growing evidence that BDNF is involved in neuronal plasticity, including LTP. We plan to extend these findings to GDNF. Our hypothesis is that the role of BDNF and GDNF in LTP is via transcriptional regulation of GluR2 synthesis. We will use the approach of examining dynamic changes in trophic factor expression resulting from LTP and compare these responses in young and old animals. We will determine if alterations in neurotrophic-factor regulation of GluR2 synthesis are important in the observed age-related deficit in late-phase LTP. We will examine the effect of GDNF and GFRa1 heterozygous gene deletions on GIuR2 Flip/Flop splice variants. A second hypothesis is that neurotrophins are important in the cellular response to oxidative stress. We plan to examine if the heterozygous gene deletions for GDNF or GFRal alter the sensitivity of the brain to oxidative insults and to examine if antioxidant treatments can improve trophic factor expression in the aged brain.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG004418-19
Application #
6611066
Study Section
Special Emphasis Panel (ZAG1)
Project Start
2002-07-15
Project End
2003-06-30
Budget Start
Budget End
Support Year
19
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Karolinska Institute
Department
Type
DUNS #
350582235
City
Stockholm
State
Country
Sweden
Zip Code
171 77
Bickford, Paula C; Flowers, Antwoine; Grimmig, Bethany (2017) Aging leads to altered microglial function that reduces brain resiliency increasing vulnerability to neurodegenerative diseases. Exp Gerontol 94:4-8
Grimmig, Bethany; Kim, Seol-Hee; Nash, Kevin et al. (2017) Neuroprotective mechanisms of astaxanthin: a potential therapeutic role in preserving cognitive function in age and neurodegeneration. Geroscience 39:19-32
Tajiri, Naoki; Acosta, Sandra A; Shahaduzzaman, Md et al. (2014) Intravenous transplants of human adipose-derived stem cell protect the brain from traumatic brain injury-induced neurodegeneration and motor and cognitive impairments: cell graft biodistribution and soluble factors in young and aged rats. J Neurosci 34:313-26
Lee, Daniel C; Ruiz, Claudia R; Lebson, Lori et al. (2013) Aging enhances classical activation but mitigates alternative activation in the central nervous system. Neurobiol Aging 34:1610-20
Lee, D C; Rizer, J; Hunt, J B et al. (2013) Review: experimental manipulations of microglia in mouse models of Alzheimer's pathology: activation reduces amyloid but hastens tau pathology. Neuropathol Appl Neurobiol 39:69-85
Ross, Jaime M; Stewart, James B; Hagström, Erik et al. (2013) Germline mitochondrial DNA mutations aggravate ageing and can impair brain development. Nature 501:412-5
Shahaduzzaman, Md; Golden, Jason E; Green, Suzanne et al. (2013) A single administration of human umbilical cord blood T cells produces long-lasting effects in the aging hippocampus. Age (Dordr) 35:2071-87
Olson, Linus; Faulkner, Stuart; Lundströmer, Karin et al. (2013) Comparison of three hypothermic target temperatures for the treatment of hypoxic ischemia: mRNA level responses of eight genes in the piglet brain. Transl Stroke Res 4:248-57
Morganti, Josh M; Nash, Kevin R; Grimmig, Bethany A et al. (2012) The soluble isoform of CX3CL1 is necessary for neuroprotection in a mouse model of Parkinson's disease. J Neurosci 32:14592-601
Li, Qingyou; Lebson, Lori; Lee, Daniel C et al. (2012) Chronological age impacts immunotherapy and monocyte uptake independent of amyloid load. J Neuroimmune Pharmacol 7:202-14

Showing the most recent 10 out of 317 publications